News
CVSI
0.059
-7.81%
-0.005
Weekly Report: what happened at CVSI last week (1222-1226)?
Weekly Report · 12/29/2025 10:18
Trump Trade: U.S. delays tariffs on Chinese semiconductors
TipRanks · 12/24/2025 14:50
Trump orders rescheduling of cannabis by end of January, Marijuana Herald says
TipRanks · 12/23/2025 20:10
Weekly Report: what happened at CVSI last week (1215-1219)?
Weekly Report · 12/22/2025 10:18
Trump Trade: Trump increasing medical marijuana, cannabidiol research
TipRanks · 12/19/2025 15:10
Alliance Global says mandate for cannabis banking could come at another time
TipRanks · 12/18/2025 20:35
Trump increasing medical marijuana and cannabidiol research
TipRanks · 12/18/2025 19:20
President Trump says marijuana order ‘not legalization’
TipRanks · 12/18/2025 18:55
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Benzinga · 12/17/2025 13:38
Trump Trade: Office of Personnel Management launching U.S. Tech Force
TipRanks · 12/16/2025 15:11
Trump says looking at reclassifying mariijuana ‘very strongly,’ Bloomberg says
TipRanks · 12/15/2025 20:50
Weekly Report: what happened at CVSI last week (1208-1212)?
Weekly Report · 12/15/2025 10:25
Odds On: Traders on Kalshi see 4% chance of cannabis rescheduling this month
TipRanks · 12/12/2025 20:40
Trump Weekly: Nvidia AI chips unusual review, marijuana order expected
TipRanks · 12/12/2025 19:40
Video: Cannabis stocks jump as Trump expected to ease federal restrictions
TipRanks · 12/12/2025 18:35
Midday Fly By: Broadcom slides, pot stocks jump
TipRanks · 12/12/2025 17:15
Cannabis stocks jump on anticipated order to reclassify marijuana
TipRanks · 12/12/2025 17:00
Trump expected to sign EO to reclassify marijuana as soon as Monday, CNBC says
TipRanks · 12/12/2025 16:15
Trump Trade: Trump aiming to reduce restrictions on marijuana
TipRanks · 12/12/2025 15:15
Roth Capital positive on ‘immediate upside’ from cannabis scheduling change
TipRanks · 12/12/2025 13:41
More
Webull provides a variety of real-time CVSI stock news. You can receive the latest news about Cv Sciences through multiple platforms. This information may help you make smarter investment decisions.
About CVSI
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.